I'm pretty excited about what some of these additions mean for the direction of YC. More enterprise/B2B experience, more bio-tech experience - YC is pretty awesome, so diversifying to more spaces will just make more spaces awesome.
* And not primarily because of Elizabeth – who I'm sure is fantastic – but more broadly because of what it signals with regards to YC's focus and energy.